A Category on the Rise
Women’s health has evolved from a niche segment within nutraceuticals to one of its most dynamic growth categories. Across the Asia–Pacific region, the category is forecast to exceed USD 8 billion by 2028, driven by consumer demand for solutions targeting energy, hormonal balance, fertility, cognition and healthy ageing.[1]
This surge reflects a shift from symptom management to functional optimisation. Women are increasingly seeking science-backed strategies to sustain performance, resilience and vitality throughout life stages.
Mitochondria: The Common Thread
At the centre of this evolution lies mitochondrial health. Mitochondria are not only the body’s energy producers, they are integral to hormone synthesis, cardiovascular tone, oxidative balance and cellular communication.
Research indicates that mitochondrial efficiency declines with age[2]. Supporting mitochondrial function may therefore underpin multiple outcomes, from sustained energy to fertility, metabolic control and cognitive clarity.
Clinical & Commercial Significance
For brandholders and practitioners, this represents both scientific and market opportunities.
Clinically, interventions that target mitochondrial performance align with the growing emphasis on preventative, integrative care.
Commercially, brands that can demonstrate evidence-based mitochondrial benefits are well positioned to capture a sophisticated consumer segment – one willing to invest in proven, premium formulations.
Formulators are increasingly incorporating cofactors such as Ubiquinol, which supports electron transport and antioxidant defence, into products designed for female vitality and healthy ageing. These innovations are reframing women’s health from a reactive to a proactive space.
Education as Differentiation
As the category matures, education is emerging as a key differentiator. Both practitioners and brandholders are seeking credible partners who can translate complex mitochondrial science into clear, actionable insight — helping them build trust with their audiences.
Those who lead with evidence will define the next era of women’s health innovation.
Recognition & Momentum
Reflecting this trend, Kaneka Ubiquinol™ was recently named a finalist in the NutraIngredients-Asia Awards 2025 for Innovation in Women’s Health.
While external recognition is deeply valued, this acknowledgement reinforces Kaneka’s ongoing efforts to advance the science of Ubiquinol in women’s health — bridging evidence, education and innovation to elevate the global standard of mitochondrial support. It reflects not only clinical credibility, but a sustained commitment to supporting brandholders translate research into meaningful formulations that support women’s well-being across every stage of life.
Read more about the award: https://ubiquinol.net.au/finalist-nutraingedients-asia-awards-2025/
References:
[1] Market Report Analytics. Global Perspectives on Women Health Supplement Growth: 2025-2033 Insights. Jul 22 2025. https://www.marketreportanalytics.com/reports/women-health-supplement-188106#summary
[2] Kalén A, et al. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989;24(7):579-584.